Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum NervGen Pharma Corp NGENF

Primary Symbol: V.NGEN

Healthcare

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a... see more

Add To Watchlist

Bullboard (TSXV:NGEN)

View:

(0)
•••

Post by PressReleaseon Apr 17, 2024 9:01am

New Press Release - NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates

Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024CA$23 million bought deal financing completed in March 2024 provides expected cash runway through Q3 2025 Fast Track designation granted by U.S. Food and Drug Administration (FDA) for NVG-291 in...read article.

Post by deepoil0808on Apr 09, 2024 11:38pm

UGLY chart speaks VOLUMES

I am thinking out loud. If the treatment really worked we would have seen a soaring stock price as results are evident by staff, by doctors, by family members etc.... It would be tough ...more

276

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

(0)
•••

Post by PressReleaseon Mar 28, 2024 9:02am

New Press Release - NervGen Completes $23 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - NervGen Pharma Corp. (TSXV: NGEN) ("NervGen" or the "Company") is pleased to announce the closing of its previously announced public...read article.

Post by deepoil0808on Mar 26, 2024 11:44am

Stock sharply down from $ 3.80/share (leaked results???)

Stock has dropped SHARPLY from $ 3.80 per share. Sadly, shareholders are always the last to know. From reading the chart one would speculate that the trial results either are failing or ...more

337

Comment by holliganzon Mar 22, 2024 9:43am

RE:Bought deal RAISES questions. Why now?

the insider your referring to that sold was a director exercising stock options that were expiring. They only had enough cash for this trial. If the trial is successful they have fast track ...more

274

Discussion

Post by deepoil0808on Mar 21, 2024 7:34pm

Bought deal RAISES questions. Why now?

Stock has plunged from +/- $ 3.80 to $ 2.48 today, a big drop. One insider sold +/- 30% of their holdings at $ 3 Market place published an article PROMOTING the company while a bought deal of $ 20 ...more

374

Discussion

(0)
•••

Post by PressReleaseon Mar 21, 2024 4:34pm

New Press Release - Canadian Investment Regulatory Organization Trade Resumption - NGEN

VANCOUVER, BC, March 21, 2024 /CNW/ - Trading resumes in:Company: NervGen Pharma Corp.TSX-Venture Symbol: NGENAll Issues: YesResumption (ET): 8:00 AM03/22/2024CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...read article.

(0)
•••

Post by PressReleaseon Mar 21, 2024 4:02pm

New Press Release - NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./VANCOUVER, BC, March 21, 2024 /CNW/ - NervGen Pharma Corp. ("NervGen" or the "Company") (TSXV: NGEN) is pleased to announce that it has entered into an agreement with a syndicate of underwriters...read article.

(0)
•••

Post by PressReleaseon Mar 21, 2024 3:50pm

New Press Release - Canadian Investment Regulatory Organization Trading Halt - NGEN

VANCOUVER, BC, March 21, 2024 /CNW/ - The following issues have been halted by CIROCompany: NervGen Pharma Corp.TSX-Venture Symbol: NGEN All Issues: YesReason: Pending NewsHalt Time (ET): 3:43 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a...read article.

Comment by Pandoraon Mar 20, 2024 8:17pm

RE:Article

It's over my head but would this "NerveGen" medicine have any value in combating "Peripheral Neuropathy"?

Discussion

Post by snarkymavenon Mar 20, 2024 12:47pm

Article

https://themarketonline.ca/can-nervgen-keep-a-lid-on-explosive-news-2024-03-20/

181

Discussion

Comment by snarkymavenon Mar 20, 2024 12:46pm

RE:Brian Bayley sold 100,000 shares at $ 3/share

There are insiders with large positions of stock at $1 that has a vesting date which is around now. If they do not sell their shares, they lose out. All any insider knows is if they ...more

239

Discussion

Comment by snarkymavenon Mar 20, 2024 12:42pm

RE:RE:RE:RE:Brian Bayley sold 100,000 shares at $ 3/share

There are insiders with large positions of stock at $1 that has a vesting date which is around now. If they do not sell their shares, they lose out. All any insider knows is if they ...more

160

Discussion

Comment by deepoil0808on Mar 19, 2024 3:19pm

RE:RE:RE:RE:Brian Bayley sold 100,000 shares at $ 3/share

I agree. Fact that observers can see the trial`s success makes it very easy to know if it works or not. Perhaps that one person who showed a little improvement was due to ...more

236

Discussion